Mitochondrial dysfunction as a driver of chronic pain: New insights and therapeutic prospects
Pharmacological Research · 2026-05 · 227 · 108170
DOI: 10.1016/j.phrs.2026.108170 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026-05. Verfasst von Yi-Lin Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Resea…. Hauptthemen laut MEDLINE: Mitochondria, Chronic Pain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tongji Hospital, National Key Research and Development Program of China Stem Cell and Translational Research.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Chronic pain is a significant global health burden often resistant to conventional analgesics. Evidence implicates that mitochondrial dysfunction is not only a cellular consequence of injury, but also a fundamental driver of pain chronification. This review synthesizes current insights into how mitochondrial impairment contributes to pain chronification across diverse pathological contexts. Bioenergetic failure marked by ATP depletion and electron transport chain defects plays a central role. This energy crisis converges with oxidative stress, calcium overload, and neuroinflammation to promote neuronal hyperexcitability. Meanwhile, impaired mitophagy, suppressed biogenesis, and abnormal dynamics all contribute to the disrupted mitochondrial quality control, which further perpetuates cellular stress. Crucially, the efficacy of multiple mitochondria-targeted therapeutic strategies was summarized in this review. Despite gaps in current research, we emphasize that developments in biomarker and exploration of neuro-glial immune interactions could advance mitochondria-based precision medicine for pain management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical C…
Förderung
- National Natural Science Foundation of China
- Tongji Hospital
- National Key Research and Development Program of China Stem Cell and Translational Research
- National Key Research and Development Program of China
Zitieren
APA
Fan, Y. L., Dai, F. Y., Wang, J. Y., Dai, X. Y., Song, W. L., Wu, H., Gao, S. J., Tao, M., Zhang, L. Q., Liu, T. Z., Yang, S. G., Liu, D. Q., Zhou, Y. Q., & Mei, W. (2026). Mitochondrial dysfunction as a driver of chronic pain: New insights and therapeutic prospects. Pharmacological Research, 227, 108170. https://doi.org/10.1016/j.phrs.2026.108170
Vancouver
Fan YL, Dai FY, Wang JY, Dai XY, Song WL, Wu H, et al. Mitochondrial dysfunction as a driver of chronic pain: New insights and therapeutic prospects. Pharmacological Research. 2026;227:108170. doi:10.1016/j.phrs.2026.108170
BibTeX
@article{Fan2026,
author = {Fan, Yi-Lin and Dai, Fang-Yu and Wang, Jia-Yi and Dai, Xin-Yi and Song, Wen-Lu and Wu, Hong and Gao, Shao-Jie and Tao, Mei and Zhang, Long-Qing and Liu, Tian-Zhu and Yang, Shu-Guang and Liu, Dai-Qiang and Zhou, Ya-Qun and Mei, Wei},
title = {Mitochondrial dysfunction as a driver of chronic pain: New insights and therapeutic prospects},
journal = {Pharmacological Research},
year = {2026},
volume = {227},
pages = {108170},
doi = {10.1016/j.phrs.2026.108170}
}
EUVIMED